Ana Rodrigues
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ana Rodrigues has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Cristina Ferreira
Gulbenkian Institute for Molecular Medicine, Lisbon, Portugal
2 shared publications - Helena Nunes-Cabaço
GIMM - Gulbenkian Institute for Molecular Medicine, Avenida Prof. Egas Moniz, Lisboa, Portugal
2 shared publications - Marc Veldhoen
Gulbenkian Institute for Molecular Medicine, Lisbon, Portugal
2 shared publications - Maria Manuel Mota
Gulbenkian Institute for Molecular Medicine, Lisbon, Portugal
2 shared publications - Miguel Prudêncio
GIMM - Gulbenkian Institute for Molecular Medicine, Avenida Prof. Egas Moniz, Lisboa, Portugal
2 shared publications - Nuno Valente-Leal
Gulbenkian Institute for Molecular Medicine, Lisbon, Portugal
2 shared publications
Latest Publications
- Open Access
- 30 September 2026
- Published by Springer Nature in Nature Microbiology
- Vol. 11 (11) , 3180-3192
Host cell traversal by Plasmodium parasites drives sterilizing T cell-mediated immunity following immunization
The development of a vaccine capable of conferring sterile protection against Plasmodium , the causative agent of malaria, is a major priority for global eradication efforts. Whole-organism vaccines using liver-infective sporozoites provide high levels of sterile protection against pre-erythrocytic infection. Yet, determinants of sporozoite immunogenicity remain poorly characterized. Here we demonstrate, using rodent models of vaccination, that the ability of Plasmodium sporozoites to actively migrate through multiple host cells before infecting hepatocytes is required for sterilizing immunity, regardless of the extent of intrahepatic development of immunizing parasites. We further establish host cell traversal as a dominant contributor to the induction of sterile protection. Impaired cell traversal precludes protective liver-resident memory CD8 T cell responses following vaccination but not the production of antiplasmodial antibodies. Our findings show that intrahepatic parasite development alone does not fully account for the magnitude and durability of protection induced by whole-sporozoite vaccination, and highlight parasite behaviour traits as critical immunogenic events shaping sterilizing cellular immunity against Plasmodium liver stages.
- 30 September 2026
- Published by Springer Nature in Nature Microbiology
- Vol. 11 (11) , 3180-3192
Open AccessHost cell traversal by Plasmodium parasites drives sterilizing T cell-mediated immunity following immunization
The development of a vaccine capable of conferring sterile protection against Plasmodium , the causative agent of malaria, is a major priority for global eradication efforts. Whole-organism vaccines using liver-infective sporozoites provide high levels of sterile protection against pre-erythrocytic infection. Yet, determinants of sporozoite immunogenicity remain poorly characterized. Here we demonstrate, using rodent models of vaccination, that the ability of Plasmodium sporozoites to actively migrate through multiple host cells before infecting hepatocytes is required for sterilizing immunity, regardless of the extent of intrahepatic development of immunizing parasites. We further establish host cell traversal as a dominant contributor to the induction of sterile protection. Impaired cell traversal precludes protective liver-resident memory CD8 T cell responses following vaccination but not the production of antiplasmodial antibodies. Our findings show that intrahepatic parasite development alone does not fully account for the magnitude and durability of protection induced by whole-sporozoite vaccination, and highlight parasite behaviour traits as critical immunogenic events shaping sterilizing cellular immunity against Plasmodium liver stages.
- Open Access
Host cell traversal by Plasmodium parasites is essential for sterilizing hepatic cellular immunity
SUMMARY: An effective vaccine capable of inducing sterile protection against Plasmodium , the causative agent of malaria, is critical to aid global eradication. Whole-organism vaccines using liver-infective sporozoites provide high levels of sterile protection against pre-erythrocytic infection. Yet, determinants of sporozoite immunogenicity remain poorly characterized. Using rodent models of vaccination, we demonstrate that the ability of Plasmodium sporozoites to actively migrate through multiple host cells prior to infecting hepatocytes is required for sterilizing immunity, regardless of the time of intrahepatic development of immunizing parasites. We further establish that host cell traversal is sufficient to trigger robust protection against Plasmodium hepatic infection. Impaired cell traversal precludes protective liver-resident memory CD8 T cell responses following vaccination, but not the production of anti-plasmodial antibodies. Our findings challenge the prevailing notion that intrahepatic parasite development is the sole determinant of whole-sporozoite vaccination-induced protection, and highlight parasite behavior traits as critical immunogenic events shaping sterilizing cellular immunity against Plasmodium liver stages.
Open AccessHost cell traversal by Plasmodium parasites is essential for sterilizing hepatic cellular immunity
SUMMARY: An effective vaccine capable of inducing sterile protection against Plasmodium , the causative agent of malaria, is critical to aid global eradication. Whole-organism vaccines using liver-infective sporozoites provide high levels of sterile protection against pre-erythrocytic infection. Yet, determinants of sporozoite immunogenicity remain poorly characterized. Using rodent models of vaccination, we demonstrate that the ability of Plasmodium sporozoites to actively migrate through multiple host cells prior to infecting hepatocytes is required for sterilizing immunity, regardless of the time of intrahepatic development of immunizing parasites. We further establish that host cell traversal is sufficient to trigger robust protection against Plasmodium hepatic infection. Impaired cell traversal precludes protective liver-resident memory CD8 T cell responses following vaccination, but not the production of anti-plasmodial antibodies. Our findings challenge the prevailing notion that intrahepatic parasite development is the sole determinant of whole-sporozoite vaccination-induced protection, and highlight parasite behavior traits as critical immunogenic events shaping sterilizing cellular immunity against Plasmodium liver stages.